In the following paragraphs, we will focus on specific ECM components that could play an important role in the development of epilepsy in brain tumors: matrix metalloproteinases, urokinase-type plasminogen activator receptor, leucine-rich glioma inactivated 1, and glypicans. The gene discussed is GPC1; the disease is epilepsy.